EUVIMED · CrossrefZeitschrift
Clinical Immunology
ISSN 1521-6616 · Elsevier BV
Neueste Artikel
TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue
T-cell activation profiles predict outcomes of neoadjuvant therapy in breast cancer
Plasma anti-ATP7A/ATP7B/COPT1 autoantibodies as potential biomarkers for breast cancer detection
Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma
Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis
Clinical immunology lessons from failed α-Synuclein and Tau immunotherapies: A roadmap for combination strategies in Alzheimer's disease
The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus
TIGIT regulates CD8+T cell exhaustion via the PI3K/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma
Development of bi-functional hybrid IgGA antibodies for enhancing cancer immunotherapy
Advances in genetically engineered and humanized mouse models for dissecting sepsis mechanisms and therapeutic response
Ex vivo expansion reshapes invariant natural killer T-cell state, function, and therapeutic fitness
Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer
Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia
A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome
Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets
Immunoglobulin replacement therapy for the management of hypogammaglobulinemia and secondary immunodeficiency following B-cell targeted therapies in patients with autoimmune diseases: A systematic-narrative hybrid review
Antibody-negative autoimmune encephalitis: From clinical diagnosis to antigen discovery
Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities
Monocyte–macrophage transcriptional features in esophageal squamous cell carcinoma: An exploratory prognostic signature and the potential role of DDX39A
LGALS9 interacts with CD44 on CD8+ T cells to impair activation and mediate immune evasion in nasopharyngeal carcinoma
VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis
A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy
EIF4A3/ALKBH5 axis promotes meningioma cell growth, invasion, and resistance to CD8+ T cell–mediated cytotoxicity by inducing M2 polarization
Selective immune modulation in seminal plasma during simian immunodeficiency virus infection despite systemic inflammation
Immunopathogenesis of NMDA receptor encephalitis
The LCE3D/TGF-β1 Axis in atopic dermatitis: Expression profiling, clinical significance, and mechanistic insights into epithelial-immune crosstalk
T peripheral helper 1 cells effectively drive atypical double-negative CD11chi B cells to antibody-secreting cells and play a pathogenic role in systemic lupus erythematosus
Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia
Ruxolitinib for life-threatening corticosteroid-refractory hypereosinophilic syndrome: A multicenter case series
Lymphocyte-derived microRNA hsa-miR-150-5p as a marker of inflammation-related kidney function impairment in the general population
EUVIMED